| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3879377 | The Journal of Urology | 2007 | 5 Pages |
Abstract
While weekly application of both cytotoxic agents was well tolerated, this study demonstrates the superiority of docetaxel vs vinorelbine as monotherapy in the treatment of androgen independent prostate cancer.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Michael Krainer, Sandra Tomek, Katarzyna Elandt, Peter Horak, Walter Albrecht, Michael Eisenmenger, Wolfgang Höltl, Paul Schramek, Walter Stackl, Christoph Zielinski, Jochen Reibenwein,